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Ischemia causes rapidly progressive nephropathy in the diabetic rat.
We examined the influence of renal ischemia in rats with diabetes mellitus
(DM). Male Wistar rats were rendered diabetic by streptozotocin treat-
ment. Two weeks later, 30 minutes of complete ischemia was induced in
the left kidney of DM and non-DM animals. Both groups were evaluated
functionally and morphologically four or eight weeks post-ischemia. In
non-DM animals renal function and morphology showed almost complete
recovery. In the DM animals, however, this comparatively short period of
ischemia caused a substantial loss of renal function. Four weeks post-
ischemia inulin clearance in the DM kidneys rendered ischemic was only
20% of that in the corresponding non-DM kidneys, and after eight weeks
the DM kidneys were completely anuric. Extensive inflammation and
tubulointerstitial fibrosis were evident in DM kidneys four weeks after
ischemia and seemed to increase over time. After eight weeks, tubular
atrophy was found in the ischemic DM kidneys, resulting in a substantial
loss of kidney mass. We conclude that in diabetic rats renal ischemia
causes rapidly progressive kidney damage that in several respects resem-
bles diabetic nephropathy in humans. Since advanced renal lesions similar
to those seen in human diabetic nephropathy never develop in the rat
solely as a result of DM, the present study may provide an experimental
model for further studies on renal failure in diabetes mellitus.
In experimental rodent models of diabetes mellitus (DM),
advanced lesions similar to those seen in human diabetic nephrop-
athy never develop. Only early signs of diabetic renal injury, such
as mesangial cell expansion and basal membrane thickening, are
found [1—5]. Furthermore, these early lesions can be reversed by
insulin treatment [61. The lack of severe DM nephropathy in the
rat may be due to the short lifespan, in that there is not enough
time to develop the complete syndrome. On the other hand, the
early diabetic lesions develop rapidly in experimental rodent
models. It seems possible that more severe damage, correspond-
ing to the lesions in human diabetic nephropathy, requires other
factors for its development in addition to insulin deficiency and
hyperglycemia. One such possible factor is ischemia.
More than 30 years ago Thomsen suggested that some of the
pathological findings in diabetic nephropathy, in particular the
interstitial inflammation and fibrosis, may be explained by isch-
emia [7]. It is now generally accepted that ischemia-reperfusion
injury causes inflammation, and diabetes has recently been found
to exacerbate this inflammatory response [8]. It has been sug-
gested that the tubulointerstitial fibrosis may be mediated by
inflammatory cells [9] and correlate with the degree of arterial
obliteration [10].
Only in a few studies has the combination of renal ischemia and
DM been assessed. Wald et al found that whereas DM rats were
more sensitive to ischemia [11], they were protected against
nephrotoxic acute tubular necrosis [11, 12]. Kuramochi and
Homma observed an abnormal decrease and recovery in oxygen
consumption in kidney slices from diabetic rats after isehemia [13,
14]. There are indications that an impaired response to nitric
oxide might lead to a more pronounced decrease in renal function
in the early post-isehemic phase in DM rats [151.
All these previous studies have concerned the early phase of
isehemie renal failure in the diabetic rat. In the present study we
investigated the long-term effect of transient renal ischemia in rats
previously made diabetic by administration of streptozotocin
(STZ). We used an ischemic period of 30 minutes, which in
non-DM animals results in almost complete recovery. In the
diabetic rats, however, both functional and morphological evalu-
ation revealed rapidly progressive renal damage. Thus, end-stage
renal failure was attained within eight weeks.
METHODS
Experimental groups and animals
Male Wistar rats (Møllegaard, Denmark) were used. They were
divided into four groups, of which two were subjected to diabetic
induction by STZ and two were used as controls, Unilateral
ischcmia was induced in all groups. The rats of one DM and one
non-DM group were examined four weeks after ischemia, and
those of the other two groups were studied eight weeks after
ischemia. For the entire duration of the experiments the animals
were kept in plastic cages and fed standard rat chow (R36;
Lactamin AB, Stockholm, Sweden) and water ad lihitum.
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induction of diabetes
Before induction of DM the rats were deprived of food
overnight but had free access to water. Under light ether anes-
thesia, a solution containing 11 mg/mI of STZ (Zanosar; Upjohn,
Kalamazoo, MI, USA) in saline with a sodium citrate buffer, pH
4.0, was injected into the femoral vein. The dose of STZ given was
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Table 1. Metabolic parameters
Values are means SEM. The arterial blood pressures shown are from when the blood sample for inulin determination was drawn.
P < 0.05 DM vs. non-DM in corresponding kidneys
"P < 0.01 DM vs. non-DM in corresponding kidneys
"P < 0.001 DM vs. non-DM in corresponding kidneys
d P < 0.05 DM vs. non-DM groups
55 mg/kg body wt. The food and water consumption, weight gain
and blood glucose levels were recorded to monitor the degree of
diabetes. Blood glucose was assayed by the glucose-dehydroge-
nase method (Granutest 250; Merck, Whitehouse Station, NJ,
USA). At least two weeks were allowed to elapse between the
induction of diabetes and the ischemic injury. The rats were
considered diabetic if the blood glucose level was above 20
mmol/liter.
Induction of ischemia
The animals were anesthetized by an intraperitoneal injection
of Eqviticin (a mixture of chloral hydrate 183 mg kg' body wt,
magnesium sulfate 0.09 mg kg' body wt and thiobarbital sodium
42 mg kg' body wt; Apoteksbolaget, Ume, Sweden). During
the operation the animals were placed on a servocontrolled
heating pad, which kept the body temperature at 37.5°C. A
midline incision was made and the left renal artery was located
and dissected free from its surrounding structures. After a recov-
ery period of 10 minutes, renal ischemia was evoked by clamping
the left renal artery for 30 minutes. Subsequently the abdomen
was sutured and the animals were returned to their cages.
Measurement of renal function
GFR was estimated from the clearance of inulin (C1,). The
animals were anesthetized and put on an electric heating pad, as
described above, and tracheostomized. Catheters were inserted
into both ureters through a supravesical incision. The right
femoral artery was catheterized for blood pressure monitoring
and withdrawal of blood samples, and the femoral vein for
infusion of saline (5 ml kg' body wt hr' in non-DM rats, and
10 ml kg body wt hr ' in DM rats); this solution also
contained 5 mCi ml 3H-inulin. After a bolus injection of 1 ml,
an equilibration period of 45 minutes was allowed to elapse. Urine
was then collected separately from both kidneys for 30 minutes. In
the middle of this period a reference blood sample was drawn.
The 3H activity in the plasma and urine was measured by the
liquid scintillation technique.
Histological evaluation
After completion of the functional studies, both kidneys were
removed and the upper third of each kidney was put into a
buffered 4% formalin fixation solution with 1% N-cetylpyridinium
chloride and processed for histological examination. The sections
were subjected to periodic acid-Schiff staining for detection of
basal membrane and cell nuclei and picro-Sirius staining for
investigation of fibrosis. The histological findings were blindly
evaluated on coded samples by two investigators together. On the
arbitrary scale used, 0 indicated no sign of inflammation, tubular
dilation or fibrosis, 1 indicated mild changes, 2 moderate damage,
and 3 severe lesions.
In order to evaluate the degree of tubular atrophy and/or
glomerular injury, the number of glomeruli in four randomly-
selected visual fields (magnification >< 160) in the cortex of each
kidney was counted. To estimate the relative glomerular size, two
photographs were taken of the cortex on sections from each
kidney. The sizes were then estimated by weighing the glomeruli
cut out from the photographs. The average size of the glomeruli
in the non-ischemic, non-DM group observed for four weeks was
put at 1 and the values in the other groups were normalized to this
value.
Statistical analysis
All data are presented as means SEM. A one-way ANOVA
test was combined with Scheffe's post hoc test to compare
physiological and metabolic variables between the experimental
Non-diabetic
4 weeks (N = 8) 8 weeks (N = 8)
Diabetic
4 weeks (N = 7) 8weeks(N = 8)
Blood glucose mmol/liter 10.7 1.1 10.1 0.5 31.2 0.9"
Water consumption mI/day 29 2 29 4 182 17"
Body weight g 294 13 365 15 240 14
28.1 1.4"
157 13"
291 10°
Values are means SEM. Diabetic animals are compared with non-diabetic animals observed for the same time.
° P < 0.01 DM vs. non-DM
"p < 0.00! DM vs. non-DM
Table 2. Renal function
Non-diabetic Diabetic
Observation time 4 weeks (N = 8) 8 weeks (N= 8) 4 weeks (N = 7) 8 weeks (N = 8)
Urinary flow p1/mm Ischemic 6.1 1.5 3.8 1.1 4.2 3.5 0"
Non-ischemic 7.6 2.1 5.7 1.6 33.7 9.7° 47.4 4.7"
C, mi/mm Ischemic 0.75 0.15 0.55 0.16 0.14 0.13" 0"
Non-ischemic 0.86 0.12 0.76 0.18 1.44 0.38 1.85 0.16"
Hct% 52±1 54±2 4331 47±2
Arterial blood pressure mmHg 73 5 64 4 69 5
0
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groups. The Mann-Whitney U-test was used for statistical com-
parisons of renal function values, number of glomeruli per visual
field and semiquantitative morphological values between DM and
corresponding non-DM kidneys from animals observed from the
same length of time. Relative glomerular size was evaluated by
pooling all relative glomerular sizes in one group and comparing
corresponding kidneys in non-DM and DM groups using a
one-way ANOVA test combined with Scheffe's post hoc test. For
statistical analyses the Statview 4.5 program (Adobe Concepts,
Berkeley, CA, USA) was used.
RESULTS
In Table 1 variables reflecting the degree of diabetes, that is,
blood glucose levels, water consumption and body weight gain, are
shown. It was evident that the STZ-treated animals were severely
diabetic, and they drank about five times more water than the
non-DM group. In spite of an increased food consumption the
DM animals gained considerably less weight than the non-DM
animals, probably due to loss of glucose in the urine. The mean
blood glucose level was 30 mmol/liter in the DM and in the
non-DM groups about 10 mmol/liter. Ketonuria was not present,
however, indicating that some insulin production was spared.
In the DM animals, ischemia caused a substantial decrease in
C1,, to less than 20% of that in the non-DM post-ischemic kidneys
after four weeks. This dramatic loss of renal function led to
complete anuria within eight weeks post-ischemia. A compensa-
tory increase in GFR in the contralateral non-ischemic kidney was
found in the DM animals (Table 2).
Morphology
Hypertrophy of the non-ischemic DM kidneys was evident from
a substantial increase in kidney size both four and eight weeks
after the ischemic insult on the contralateral kidney. In the
post-ischemic DM kidneys, however, no increase in size was seen
after four weeks, and after eight weeks a substantial decrease in
size was noted. Marked scarring was observed on the kidney
surface four weeks post-ischemia, and this was even more pro-
nounced after eight weeks.
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Fig. 1. Semiquantitative morphological evaluation of renal lesions. The number of animals is 7 or 8 except in papilla where it is 7 to 5. Symbols are:(E) 4 weeks non-ischemic; (E]) 4 weeks ischemic; () 8 weeks non-ischemic; (•) 8 weeks ischemic. On the arbitrary scale used 0 indicated no sign of
inflammation, tubular dilation or fibrosis, I indicated mild changes, 2 moderate damage, and 3 severe lesions. All values are means SEM. < 0.05
DM versus non-DM in corresponding kidneys, '"P < 0.01 DM versus non-DM in corresponding kidneys and "'"P < 0.001 DM versus non-DM in
corresponding kidneys. Note that when no bar is shown the value is zero.
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Fig. 2. Photomicrographs of Picro-sirius staining showing fibrosis. Severe fibrosis could be noted in the DM-kidneys subjected to ischemia especially
after eight weeks. In the non-DM ischemic groups only small signs of fibrosis were present. In the DM kidneys subjected to ischemia pronounced tubular
dilation was evident. Decrease in size and in the relative number of glomeruli in the cortex was obvious eight weeks post-ischemia due to tubular atrophy.
Magnification X 70.
In the DM kidneys subjected to ischemia, infiltration of inflam-
matory cells consisting chiefly in macrophages and small lympho-
cytes, was found in all renal compartments except the glomeruli
(Fig. 1). The inflammation was extensive both in the cortex and in
the outer medulla and seemed to increase over time. In the papilla
inflammatory cells were less frequent. In non-diabetic post-
ischemic kidneys inflammatory cells were found only occasionally.
In the post-ischemic DM kidneys extensive fibrosis was ob-
served both in the cortex and outer medulla (Figs. I and 2). Large
areas of these kidneys were fibrotic and filled with inflammatory
cells, and in these areas tubular structures could not be clearly
identified. Eight weeks after the injury there was a marked
increase in he number of glomeruli per visual field in the DM
kidneys subjected to ischemia, indicating substantial tubular atro-
phy (Table 3). Tubular casts were only occasionally seen. In all
DM kidneys subjected to ischemia pronounced tubular dilation
was evident (Figs. 1, 2 and 3).
In the post-ischemic DM kidneys the glomcruli appeared
heterogeneous. At four weeks post-ischemia some glomeruli were
atrophic and sclerotic but most of them appeared almost normal,
apart from thickening of Bowman's capsule (Fig. 3). Eight weeks
after the ischemic insult the number of small and sclerotic
glomeruli had increased. The relative glomerular size in the
non-ischemic DM kidneys had increased by roughly one third
after four weeks and by about two thirds after eight weeks (Table
3). In contrast, the glomeruli of the DM kidneys subjected to
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Table 3. Relative glomerular size and number per visual field
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4 weeks 8 weeks 4 weeks 8 weeks
(N = 8 rats) (N = 8 rats) (N = 7 rats) (N 8 rats)
Relative glomerular size Non-ischemic 1.00 0.04 1.13 0.03 1.37 0.04c 1.69 0.05c
N glomeruli 100 91 66 75
Ischemic 1.05 0.04 1.26 0.05 0.95 0.04 0.85 0.02c
N glomeruli 90 89 88 177
Number of glomeruli per visual field Non-ischemic
Ischemic
4.4 0.4
3.4 0.3
4.1 0.2
5.2 0.4
3.1 OP
4.1 0.7
3.1 0.3a
11.4
ischemia showed no hypertrophy at four weeks, and after eight
weeks they were decreased in size.
DISCUSSION
The utility of experimental rodent models as a reflection of
human diabetic nephropathy is limited, since advanced lesions
never develop in the diabetic rat. In the present study we have
shown that a comparatively short ischemic period of 30 minutes,
from which the normal rat almost completely recovers, causes a
rapidly progressive nephropathy and end-stage renal failure in the
diabetic rat.
Several investigators have addressed the question of kidney
injury in rodent diabetic models. Evan et al found only mild
vacuolization in tubular cells after eight weeks of diabetes mellitus
(DM), which was ameliorated by insulin treatment [6]. In strep-
tozotocin (STZ)-DM kidneys followed for 30 weeks, Yong and
Bleasel observed sparse fibrinoid glomerular lesions [4]. Hirose et
al studied STZ-DM for up to 18 months, but still advanced lesions
did not develop [2]. This is in accordance with the finding in the
present study that lesions were sparse in the non-ischemic DM
kidneys. These kidneys exhibited hypertrophy and hyperfiltration
typical for DM rats [4, 16]. The hyperfiltration is known to be
further increased by unilateral nephrectomy [3]. From a func-
tional point of view, the unilateral ischemia in the DM animals in
the present study may be considered equivalent to unilateral
nepherctomy. This would explain the hypertrophy and hyperfil-
tration observed in the contralateral kidney.
The renal damage observed in the DM animals after ischeniia
differs substantially from that seen after ischemia-reperfusion in
non-DM animals. The present injury is clearly progressive,
whereas renal ischemia in the nonDM rat causes a functional
impairment that is most pronounced one to two weeks after the
ischemia and is followed by substantial recovery [17, 18]. In the
present study 30 minutes of ischemia resulted in an almost
completely reversible injury in the nori-DM rats. With more
extensive ischemia, that is, 60 minutes or more, the outcome may
be a substantial loss of kidney mass and renal function even in
non-DM animals. Nevertheless, in such animals maximal recovery
is completed within four to eight weeks [18].
In principal the present injury could be explained in two ways.
One possibility is an extreme susceptibility of the diabetic kidney
to ischemia and the other is the presence of some yet unknown
mechanism in diabetes that is triggered by ischemia and subse-
quently drives an inflammatory and fibrotic process.
Increased sensitivity to ischemia may be expected from the
increase in Na,K-ATPase activity and thereby the increased
oxygen demand along most segments of the nephron in STZ-
diabetic rats [19]. Furthermore, hyperglycemia is associated with
an increased ratio of free NADH/NAD+ similar to that found in
hypoxia. This so-called pseudohypoxic state is associated with
abnormalities in several cellular pathways [20]. Ischemia is likely
to increase the NADH/NAD+ ratio further.
In the diabetic rat an increased sensitivity to renal ischemia has
been demonstrated previously. Wald et al found that diabetic rats
subjected to one hour of bilateral renal artery clamping died
within 48 hours [11], while most non-diabetic animals survived the
ischemic injury. A delayed recovery of oxygen consumption in
slices from diabetic rat kidneys subjected to ischemia has been
reported [13, 14], and it has been suggested that a more pro-
nounced decrease in renal function after ischemia in diabetic rats
may be due to an impaired response to nitric oxide in these
animals [15].
All these previous studies, however, have concerned the early
phase of ischemic injury. Further, they have used a more severe
ischemic injury resulting from 60 minutes of clamping of the renal
artery. This substantial ischemia will in most instances cause
considerable irreversible kidney damage even in the normal,
non-DM rat [18]. In the present study the ischemic period was
only 30 minutes and in the non-DM rats was associated with
almost complete recovery of renal function and morphology. In
the diabetic rats, however, end-stage renal failure developed after
eight weeks, Since the injury continues to progress from the fourth
to the eighth week post-ischemia, the final injury is probably not
entirely due to increased sensitivity to isehemiaperse. In addition,
ischemia-reperfusion seems to trigger some other, yet unidenti-
fled mechanism that comes into play and drives an inflammatory-
fibrotic process affecting primarily the tubules and interstitium. In
the present model glomerular injury seems to be a subsequent
event. Glomerular atrophy and glomerulosclerosis were not pro-
nounced until eight weeks after ischemia.
The extensive tubulointerstitial inflammation in the present
study may at first seem contradictory to the well established view
that glomerular injury is the hallmark of diabetic nephropathy.
More than 30 years ago, however, Thomsen [7] observed in a
series of renal biopsy specimens from patients with diabetic
nephropathy that round cell infiltration was evident in a majority
of the patients, indicating chronic pyelonephritis, although no
correlation to bacteriuria or other signs of urinary infection was
Non-diabetic Diabetic
All values are means SEM. N is number.
P < 0.05 DM vs. non DM in corresponding kidneys
b P < 0.01 DM vs. non DM in corresponding kidneys
P < 0.001 DM vs. non-DM in corresponding kidneys
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Non-diabetic Diabetic
Fig. 3. Photomicrographs from kidneys eight weeks post-ischcmia, PAS-staining. Cortical section from non-DM rat CA). Cortical section from DM rat
(B). Tubular dilation and infiltration of inflammatory cells could be noted. Medullary section from non-DM rat (C). Mcdullary section from DM rat.
Tubular dilation and atrophy is present along with pronounced inflammation (D). Magnification ><495.
found. He noted that the round ccli infiltrate increased with the
duration of diabetes and the degree of vascular obliteration.
Thomsen suggested, in fact, that ischemia might be responsible
for these changes in the diabetic patient. Other pathologists have
pointed out that inflammation in renal biopsy specimens from
patients with diabetes mellitus sometimes can be as extensive as to
suggest an interstitial nephritis [10]. It has been proposed that the
renal fibrosis that is a constant finding in diabetic nephropathy
may he due to ischemia [101 and/or inflammation [91 Thus,
tubulointerstitial inflammation and fibrosis arc also prominent
features in human diabetic nephropathy. Furthermore, the inter-
stitial lesions correlate with renal function in humans at least as
well as do the glomerular lesions [21, 221.
Dehydration, which may aggravate ischemia-reperfuson injury,
could be suspected in our study on the basis of the very extensive
osmotic diuresis resulting from hyperglycemia. However, the high
urine flow rate and GFR and the lower hematocrit values found in
DM, as compared to non-DM animals, contradict the idea of
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volume deficiency. Although the average values for arterial blood
pressure were very low in the present study, most likely because of
the anesthetic drug used, there was no difference in this respect
between DM and non-DM animal. The low arterial blood pres-
sures may, however, explain the low values for GFR as compared
to those in rats anesthetized with barbiturates, for example.
The poor metabolic control in the STZ-DM rats may obviously
play a role in the pathogencsis of the observed lesions. However,
it should be emphasized that the DM animals in the present
model are not completely without insulin production. For in-
stance, neither ketonuria nor metabolic acidosis occurred. Other
investigators have used larger doses of STZ, which result in
complete inability to produce insulin, in which case insulin
replacement is required to avoid ketoacidosis.
Tubular dilation was extensive in DM animals after ischemia. In
contrast to the findings in a pure ischemic injury [171, intratubular
casts were not a prominent finding. The present tubular dilation is
most likely a consequence of inflammation, fibrosis and tubular
atrophy of the tubular segment distal to the dilated tubule. The
osmotic diuresis may also contribute, since tubular dilation was
more pronounced in the non-ischemic DM kidneys as com-
pared with non-DM animals, although this difference was not
significant.
In the present model the destruction of the kidney seems to
start with tubular-interstitial inflammation with fibrosis, while
glomerular lesions and renal atrophy are subsequent features.
When comparing the present model with human diabetic ne-
phropathy, however, one must keep in mind that the latter takes
several decades to evolve. In the present experimental model
end-stage renal failure is attained within eight weeks. It follows
that any mechanisms potentially involved in the development of
diabetic end-stage renal failure, for instance tuhulointerstitial
inflammation and fibrosis, will be greatly amplified in the present
rat model. One must also consider the differences in metabolic
control and the type of ischemic injury. Obviously, complete
ischemia and reperfusion does not occur in humans. Nevertheless,
renal hypoxia and reperfusion oxidant stress may result from
various physiological and pathophysilogical and conditions. Re-
gional renal hypoxia from arterial obliteration most certainly
occur in diabetic nephropathy.
In conclusion, the present study shows that ischemia causes
rapidly progressive kidney damage in diabetic rats characterized
by tubulointerstitial inflammation and fibrosis, while glomerular
atrophy seems to he a subsequent feature. As severe lesions never
develop in rodents with diabetes mellitus, the study suggests an
experimental model that may easily be applied for further
studies on the pathophysiology of progressive renal failure in
diabetes.
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